Graham A MacGregor Selected Research

Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)

5/2006	The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients.
5/2005	Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Graham A MacGregor Research Topics

Disease

24	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2003
23	Hypertension (High Blood Pressure) 05/2022 - 06/2002
7	Obesity 01/2018 - 03/2008
6	Stroke (Strokes) 01/2021 - 12/2003
6	Essential Hypertension 04/2016 - 06/2002
3	Osteoporosis 01/2020 - 08/2008
3	Diabetes Mellitus 04/2019 - 01/2016
3	Heart Failure 04/2019 - 04/2005
3	Type 2 Diabetes Mellitus (MODY) 11/2016 - 01/2016
2	Heart Diseases (Heart Disease) 01/2021 - 08/2008
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2010
2	Chronic Renal Insufficiency 04/2019 - 01/2019
2	Prehypertension 01/2019 - 12/2018
2	Dental Caries (Decay, Dental) 01/2018 - 11/2016
2	Overweight 02/2016 - 10/2015
2	Glucose Intolerance 01/2016 - 08/2008
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 03/2010 - 08/2008
2	Autosomal Dominant Polycystic Kidney (ADPKD) 09/2006 - 05/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2020
1	Liver Diseases (Liver Disease) 04/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Myocardial Infarction 10/2018
1	Insulin Resistance 01/2016
1	Confusion (Bewilderment) 04/2015
1	Noncommunicable Diseases 10/2011
1	Microvascular Rarefaction 08/2010
1	Asthma (Bronchial Asthma) 03/2010
1	Kidney Calculi (Kidney Stone) 08/2008
1	Hypercalciuria 08/2008
1	Pediatric Obesity 03/2008
1	Isolated Systolic Hypertension 07/2005
1	Proteinuria 05/2005
1	Liddle Syndrome 01/2004

Drug/Important Bio-Agent (IBA)

27	SaltsIBA 05/2022 - 12/2003
18	SodiumIBA 01/2022 - 07/2002
5	Dietary SodiumIBA 05/2022 - 01/2003
5	SugarsIBA 01/2019 - 03/2015
2	PotassiumIBA 01/2019 - 08/2008
2	AlbuminsIBA 01/2016 - 06/2002
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2006 - 05/2005
2	Sodium Channels (Sodium Channel)IBA 01/2004 - 07/2002
2	Epithelial Sodium ChannelsIBA 01/2004 - 07/2002
2	Amiloride (Midamor)FDA LinkGeneric 01/2004 - 07/2002
1	oxidized low density lipoproteinIBA 01/2021
1	CatecholaminesIBA 04/2016
1	Antihypertensive Agents (Antihypertensives)IBA 04/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2016
1	Sweetening Agents (Sweeteners)IBA 02/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	TabletsIBA 01/2016
1	Renin InhibitorsIBA 12/2009
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2009
1	ThiazidesIBA 12/2009
1	aliskiren FDA Link 12/2009
1	CalciumIBA 08/2008
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 08/2008
1	Enalapril FDA LinkGeneric 05/2006
1	Angiotensin Receptor AntagonistsIBA 05/2005
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 05/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2005
1	CreatinineIBA 07/2004
1	ElectrolytesIBA 07/2004
1	ReninIBA 07/2004
1	Sodium-Hydrogen ExchangersIBA 07/2004
1	AldosteroneIBA 01/2003
1	EnzymesIBA 01/2003
1	MineralocorticoidsIBA 01/2003
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2003
1	Pharmaceutical PreparationsIBA 07/2002
1	Proteins (Proteins, Gene)FDA Link 06/2002
1	Drug CombinationsIBA 06/2002
1	Transferrin (beta 2 Transferrin)IBA 06/2002

Therapy/Procedure

2	Therapeutics 04/2016 - 06/2002
1	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2019